Global clinical trial reveals safest, most effective antibiotics for golden staph bloodstream infections
An international clinical trial involving over 150 hospitals has identified more effective antibiotic treatments for golden staph bloodstream infections. The study suggests that cefazolin and benzylpenicillin are safer and more effective alternatives to the current standard treatment, flucloxacillin.
Why it matters
This finding could significantly reduce mortality rates for a condition that causes over 1 million deaths annually worldwide.
edited by Lisa Lock , reviewed by Robert Egan
The article reports on peer-reviewed medical research findings without political or ideological framing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in